Improving flurbiprofen brain-permeability and targeting in Alzheimer's disease by using a novel dendronised ApoE-derived peptide carrier system
Alzheimer disease (AD) is a neurodegenerative and age related disease characterised by gradual decrease in memory, caused by the abnormal accumulation of beta-amyloid (Aβ) in the brain. Recently, the incidence of AD has increased with 47 million people worldwide having this disease. Current availabl...
| Main Author: | |
|---|---|
| Published: |
University of Brighton
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.754004 |